首页> 外文OA文献 >Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel

【2h】

Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel

机译：白细胞减少症作为使用唑代酸和多西紫杉醇治疗转移前列腺癌中颌骨骨折的危险因素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hideyo Miyazaki; Hiroaki Nishimatsu; Haruki Kume; Motofumi Suzuki; Tetsuya Fujimura; Hiroshi Fukuhara; Yutaka Enomoto; Akira Ishikawa; Yasuhiko Igawa; Yoshikazu Hirano; Yukio Homma;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rho GTP酶在ω-3多不饱和脂肪酸抑制人前列腺癌PC-3细胞转移中的作用 [J] . 易龙, 张乾勇, 糜漫天癌症（英文版） . 2007,第012期
2. Does regular zoledronic acid change the bone turnover of the jaw in men with metastatic prostate cancer: A possible clue to the pathogenesis of bisphosphonate related osteonecrosis of the jaw? [J] . RistowO., Gerngro?C., SchwaigerM., Journal of Cancer Research and Clinical Oncology . 2014,第3期

机译：定期的唑来膦酸会改变患有转移性前列腺癌的男性颌骨的骨转换吗？这可能是双膦酸酯相关性颌骨坏死的发病机制的线索？
3. Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment? [J] . Pilanci Kezban Nur, Alco Gul, Ordu Cetin, Medicine. . 2015,第18期

机译：曲妥珠单抗的施用是否是接受唑来膦酸治疗的转移性乳腺癌患者下颌骨坏死的独立危险因素？
4. Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment? [J] . Pilanci Kezban Nur, Alco Gul, Ordu Cetin, Medicine. . 2015,第18期

机译：是在唑妥酸治疗下施用Trastuzumab一种在转移乳腺癌患者中发育颌骨骨折的骨折症状的独立危险因素？
5. Dietary Omega-3 Fatty Acids, Genetic Variation and Risk of Breast and Prostate Cancers [C] . Julian Mauermann, Frederic Pouliot, Vincent Fradet Inaugural Conference of the World Council on Genetics, Nutrition and Fitness for Health on the theme "Health Agriculture, Healthy Nutrition, Healthy People . 2011

机译：膳食ω-3脂肪酸，遗传变异和乳腺癌和前列腺癌的风险
6. Cost and Management of Fractures in Medicare Beneficiaries with Non-Metastatic Prostate Cancer Treated with Androgen Deprivation Therapy. [D] . Yong, Candice Yuk Chen. 2015

机译：用雄激素剥夺疗法治疗的非转移性前列腺癌医疗保险受益人骨折的成本和管理。
7. Is Administration of Trastuzumab an Independent Risk Factor for Developing Osteonecrosis of the Jaw Among Metastatic Breast Cancer Patients Under Zoledronic Acid Treatment? [O] . Kezban Nur Pilanci, Gul Alco, Cetin Ordu, -1

机译：曲妥珠单抗的施用是否是接受唑来膦酸治疗的转移性乳腺癌患者下颌骨坏死的独立危险因素？
8. A 5-year retrospective longitudinal study on the incidence and the risk factors of osteonecrosis of the jaws in patients treated with zoledronic acid for bone metastases from solid tumors [O] . Manfredi, Maddalena, Mergoni, Giovanni, Goldoni, Matteo, 2017

机译：唑来膦酸治疗实体瘤骨转移的患者颌骨坏死的发生率和危险因素的5年回顾性纵向研究

Leukopenia as a risk factor for osteonecrosis of the jaw in metastatic prostate cancer treated using zoledronic acid and docetaxel

著录项

引文网络

相似文献

相关主题

期刊订阅